[1]
H. Patel, I. Dhulia, U. Dobariya, N. Pardeshi, and Y. Katariya, “Regulatory aspects for competitive Generic Therapies in USA”, Int J Drug Reg Affairs, vol. 9, no. 2, pp. 16-19, Jun. 2021.